Najlepsze kraje do leczenia LEQEMBI® (lecanemab-irmb) for Alzheimer's za granicą 2026

Turkey provides specialized access to LEQEMBI for early-stage Alzheimer's patients. This therapy targets and removes amyloid-beta plaques to slow cognitive decline. Turkish hospitals use digital PET/CT and AI-supported 3 Tesla MRI to confirm eligibility. These tools verify amyloid buildup before starting the intensive treatment protocol.

• Cognitive preservation: Clinical studies show the treatment slows cognitive decline by 27% over 18 months.
• Precise monitoring: Centers like Memorial Göztepe Hospital use AI-supported 3 Tesla MRI for safety monitoring.
• Targeted eligibility: Doctors focus on patients with mild cognitive impairment or early-stage dementia.
• Infrastructure scale: Leading facilities feature 120+ outpatient clinics and dedicated neurology departments for therapy.

Bookimed Expert Insight: Turkish clinics concentrate Alzheimer's expertise in Istanbul. Hospitals here integrate 512-slice CT and digital PET/CT in one facility. This allows for rapid baseline testing before the first infusion. Patients can often complete the entire diagnostic workup in a single 80,000 m² building.

What patients say: Families note the importance of catching the disease early for this specific therapy. They describe the process as highly organized. The use of advanced imaging gives them confidence in the diagnosis. Many appreciate having a clear treatment plan from the start.